Menin inhibition decreases Bcl-2 and synergizes with venetoclax in NPM1/FLT3-mutated AML. Carter BZ, Tao W, Mak PY, Ostermann LB, et al. Blood 2021;138:1637-1641.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Carter BZ, Tao W, Mak PY, Ostermann LB, et al. Menin inhibition decreases Bcl-2 and synergizes with venetoclax in NPM1/FLT3-mutated AML. Blood 2021;138:1637-1641.
PMID: 34232981